commit | af6fc5c247fade6c68855e33e12dc6b7a183d75a | [log] [tgz] |
---|---|---|
author | Bazel Release System <noreply@google.com> | Thu Aug 18 13:04:21 2022 +0200 |
committer | fweikert <fwe@google.com> | Thu Aug 18 13:04:21 2022 +0200 |
tree | 13c8bb7ebe6c3e4505d3ca485e96236ea84284c0 | |
parent | 5767cba4044c2bfd8a4c9596c44d2363630b489d [diff] |
Release 6.0.0-pre.20220810.1 (2022-08-18) Baseline: 5767cba4044c2bfd8a4c9596c44d2363630b489d Incompatible changes: - Added a new flag --incompatible_unambiguous_label_stringification, which causes labels in the main repo to stringify into unambiguous forms starting with an @. See https://github.com/bazelbuild/bazel/issues/15916 for more information. This release contains contributions from many people at Google, as well as Philipp Schrader.
{Fast, Correct} - Choose two
Build and test software of any size, quickly and reliably.
Speed up your builds and tests: Bazel rebuilds only what is necessary. With advanced local and distributed caching, optimized dependency analysis and parallel execution, you get fast and incremental builds.
One tool, multiple languages: Build and test Java, C++, Android, iOS, Go, and a wide variety of other language platforms. Bazel runs on Windows, macOS, and Linux.
Scalable: Bazel helps you scale your organization, codebase, and continuous integration solution. It handles codebases of any size, in multiple repositories or a huge monorepo.
Extensible to your needs: Easily add support for new languages and platforms with Bazel's familiar extension language. Share and re-use language rules written by the growing Bazel community.
Follow our tutorials:
To report a security issue, please email security@bazel.build with a description of the issue, the steps you took to create the issue, affected versions, and, if known, mitigations for the issue. Our vulnerability management team will respond within 3 working days of your email. If the issue is confirmed as a vulnerability, we will open a Security Advisory. This project follows a 90 day disclosure timeline.
See CONTRIBUTING.md